About this trial
The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
• All pediatric patients aged 2 to 6 years.
Both sexes.
ASA physical status I and II.
Patients undergoing squint surgery.
Disqualifiers
• Refusal of parents.
Patient sensitivity to any of the study medications.
Known neurological disease that can affect the assessment of ED postoperatively.
Trial design
Parallel
Treatments tested in this trial
Ketamine
Drugcontinous infusion during surgery
Dexmedetomidine
Drugcontinous infusion during surgery
Treatment groups
Trial outcomes
Primary outcomes
The incidence of postoperative ED using PAED scale at time of admission to PACU in both groups.
During their stay at PACU, delirium will be assessed at 5, 10, 15, 20, 25, and 30 minutes following extubation via the Pediatric Anesthesia Emergence Delirium scale (PAED) . ED will be established when the child have a score of 10 or more. If the child has a score of 10 or more, rescue sedation will be done via propofol 1 mg/kg .
Sponsors and contacts
Click on the lead sponsor to view all of their trials.